About The Firm

What The Firm Offers

We offer the highest quality legal work and personal client service.

Grabar Law Office focuses on antitrust class action, securities class action, shareholder derivative litigation, consumer protection litigation, and litigation-related compliance matters.

Grabar Law Office represents businesses, universities, municipalities, institutional investors and individuals in significant antitrust, securities, shareholder and consumer litigation nationwide, as well as select serious injury and wrongful death matters.

Clients work directly with senior counsel and receive practical, litigation-informed advice designed to maximize recovery or reduce legal risk.

The Firm is committed to providing top-notch advocacy. We approach every client with a focus on integrity, trust, and understanding. We fight for you!

The Firm, and its principal, have a well-deserved reputation of excellence in providing smart, sensible, and cost-effective legal and business solutions for our clients. 

Grabar Law Office brings together lawyers and professionals with experience in complex litigation, discovery, claims development and client service. The firm's boutique structure is designed to keep experienced people close to the work.  

Learn more about the Grabar Law team of professionals here. 

Cases in which Mr. Grabar And the firm have worked or continue to work in an integral role include:

  • The Trustees of the University of Pennsylvania v. Eli Lilly and Company et al.; Case No. 2:25-cv-13210-BRM-LDW (D.N.J.) (Primary counsel for the University of Pennsylvania in a federal action alleging a conspiracy dating back to 2011 to artificially inflate the price of insulin by involving pharmaceutical manufacturers, insurance companies, and their affiliated pharmacy benefit managers).

  • In Re Masimo Corporation Stockholder Derivative Litigation, 3:24-cv-00781 (S.D. Cal.) (Co-Lead Counsel).

  • In Re Hawaiian Electric Industries and Hawaiian Electric Company Inc. Derivative Litigation, 3:23-cv-06627 (N.D. Cal.)
  • In Re Granulated Sugar Antitrust Litigation, MDL No. 24-3110 (D. Minn.)
  • S. ex rel. Valisure LLC et al. v. GlaxoSmithKline plc, et al. 2:19-cv-04239 (E.D. Pa.) (Zantac Qui Tam Litigation)
  • Midwest Renewable Energy, LLC v. Archer Daniels Midland Company, 2:20-cv-02212 (C.D. Ill.).
  • In re Deutsche Bank Spoofing Litigation, 20-cv-3638 (N.D. Ill.)
  • In re: Google Digital Advertising Antitrust Litigation, 1:21-md-03010 (S.D.N.Y.).
  • In Re: Caustic Soda Antitrust Litig., 1:19-cv-00385 (W.D.N.Y.). An antirust case alleging price fixing of Caustic Soda.
  • In Re: Cattle and Beef Antitrust Litig., 0:20-cv-1319 (D. Minn.). An antitrust case in which Direct Purchaser Plaintiffs allege that Defendants and their co-conspirators conspired to fix, raise, maintain, and stabilize the price of case-ready or boxed beef, beginning at least as early as January 1, 2015, with the result of increasing prices of such beef in the United States.
  • In Re: Local TV Advertising Antitrust Litigation, 1:2018-cv-06785 (N.D. Ill.). Plaintiffs allege a price fixing cartel facilitated by an anticompetitive information exchange between and among certain major television station owners and operators to artificially inflate the prices of broadcast television spot advertisements.
  • In Re: Capital One Customer Data Breach Litig., 19-md-02915 (E.D.Va.).
  • In Re: Juul Labs, Inc. Antitrust Litig., 3:20-cv-02345 (N.D. Cal.).
  • In Re: Generic Pharmaceuticals Pricing Antitrust Litigation, 2:16-MD-2724-CMR (E.D.PA.). An antitrust class action alleging that generic drug manufacturers conspired to fix and raise prices for numerous generic drugs, forcing consumers to pay artificially inflated prices for the medications they rely on, many of which have seen price increases of over %1000 in just the last few years, without any underlying shortage in raw material or increase in demand.
  • In Re: Blue Cross Blue Shield Antitrust Litigation, 2:13-CV-20000 (N.D. Ala.). An antitrust class action filed on behalf of Blue Cross and Blue Shield subscribers in several states who purchased individual and small group full-service commercial health insurance which seeks to enjoin the Blue Cross and Blue Shield Association and its Blue Cross and Blue Shield licensees from engaging in a continuing conspiracy in violation of the Sherman Act. The case alleges, since at least 2008 through the present, the Defendants have engaged in an anticompetitive conspiracy to establish and maintain monopoly power in thirty-eight states through market allocation agreements. The action also seeks to recover damages suffered by subscribers from inflated premiums that have been charged to them as a result of the conspiracy.
  • In Re: Cathode Ray Tube (CRT) Antitrust Litig., MDL 1917, 3:07-cv-05944 (N.D. Cal.). An antitrust action alleging price-fixing of cathode ray tubes and finished products containing cathode ray tubes, by the major manufacturers of these products with recoveries exceeding $224 million.
  • In re Steel Antitrust Litig., 08-cv-5214 (N.D. Ill.). An antitrust action alleging market allocation and supply restriction of steel by the world’s major manufacturers of steel with recoveries exceeding $163 million.
  • In Re: EPDM Antitrust Litig., MDL No. 1542 (D. Conn.). An antitrust action alleging price-fixing of Ethylene Propylene Diene Monomer with recoveries exceeding $100 million.
  • In Re: Hydrogen Peroxide Antitrust Litig., 05-CV-666 (E.D. Pa). An antitrust action alleging price-fixing of Hydrogen Peroxide with recoveries exceeding $97 million.
  • Alco Industries, Inc. v. DuPont Dow Elastomers, LLC, 1:04 CV 00588 (D.D.C.). An antitrust action alleging price-fixing of Polychloroprene Rubber with recoveries exceeding $36 million.
  • In Re: Polychloroprene Rubber (CR) Antitrust Litig., 3:05-MD-01642 (D. Conn.). An antitrust action alleging price-fixing of Polychloroprene Rubber with recoveries exceeding $15 million.
  • In Re: Methyl Methacrylate (MMA) Antitrust Litig., 2:06-MD-01768 (E.D. Pa.) (recoveries exceeding $15 million).
  • In Re: Mercedes-Benz Antitrust Litig., 99-CV-431 (AMW) (D.N.J.) (recoveries exceeding $17 million).
  • In Re: Rubber Chemicals Antitrust Litig., 03-CV-1496 (N.D. Cal.) (recoveries exceeding $250 million).

To learn more, contact us today!

Grabar Law Office

Personal Solutions
Joshua H. Grabar is focused and driven to maximize recoveries on behalf of victims of price-fixing, securities fraud and consumer fraud.

Ahead of the Curve
We are at the forefront of ever-evolving class action landscape and work closely with our clients and colleagues within the legal community to consistently exceed client expectations.

Lasting Client Relationships
Mr. Grabar is proud that so many of his clients have repeatedly turned to him for counsel and representation. He and the Firm work hard to earn their loyalty every day.

Contact Us

  • This field is for validation purposes and should be left unchanged.
  • This field is hidden when viewing the form
  • *By clicking SUBMIT you are providing express consent to receive communications from Grabar Law Office via calls, emails, and/or text messages.